[Recorded Nov. 5, 2020]
The COVID-19 pandemic has highlighted a needs for non-invasive, remote approaches to patient care.
Learn how companies like Neuroelectrics are working to bring non-invasive brain stimulation into the home. In May, 2020, Neuroelectrics received FDA approval for a clinical trial of at-home brain stimulation therapy via telemedicine for patients with Major Depressive Disorder (MDD). An additional trial with Boston Children’s Hospital (IDE G160208) is already underway, studying the therapy for treatment-resistant epilepsy.
This nonaccredited educational webinar is provided for information only.
Speaker(s):Preview Available
[Recorded Oct. 8, 2020]
What does it take to turn a big idea into a new therapy?
This engaging conversation with Eric Grigsby, MD, MBA, and David Caraway, MD PhD, explores the phases of breakthrough innovation and therapeutic development.
This nonaccredited educational webinar is provided for information only.
Preview Available
[Recorded Sept. 10, 2020]
A deep dive into how a hypothesis can change the way we think about SCS therapies and optimizing outcomes.
Dr. Vallejo unpacks the questions necessary to build a truer understanding of the effects of SCS and how the answers to these questions influence patient outcomes.
This nonaccredited educational webinar is provided for information only.
Recent Publications:
[Recorded July 16, 2020]
Rheumatoid arthritis (RA) is an autoimmune disease which leads to permanent joint destruction and accelerated mortality requiring lifelong immunosuppressive therapies. Activation of neuroimmune reflexes by vagal nerve stimulation (VNS) reduced disease activity in a proof-of-concept study in RA.
This nonaccredited educational webinar is provided for information only.
Speaker(s):Preview Available
[Recorded July 2, 2020]
Drs. Eric Grigsby, and Lawrence Poree held an in-depth conversation on equity and inclusion in pain management.
The conversation elucidates:
This nonaccredited educational webinar is provided for information only.
Additional resources:
Preview Available
[Recorded May 28, 2020]
Learn:
This nonaccredited educational webinar is provided for information only.
Speaker(s):Preview Available
[Recorded May 7, 2020]
Eric J. Grigsby, MD, MBA and NANS Board Member, Stephanie G. Vanterpool, MD, MBA review exploring NANS’ Neuromodulation Device Algorithm for COVID-19.
Learn:
This guidance refers to the management of currently implanted neuromodulation devices. With rare exception, implantation of new devices is considered elective in the current COVID-19 environment.
This nonaccredited educational webinar is provided for information only.